Pacira BioSciences, Inc. — Director's Dealing 2016

Jun 17, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2016-06-15

Reporting Person: STACK DAVID M (Director, CEO and Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-15	Common Stock	A	33125	$0.00	Acquired	33410	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-15	Stock Option (Right to Buy)	$40.34	A	66250	Acquired	2026-06-15	Common Stock (66250)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	18596	Indirect
Common Stock	1208	Indirect

Footnotes

F1: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2017, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

F2: Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC.

F3: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.